Long-term Follow-up After Adoptive Transfer of Genetically Modified Cell Products
Recruiting
Observational Study
Relapsed Hematologic Malignancy
Refractory Hematologic Malignancy
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- St. Jude Children's Research Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Human gene therapy products are designed to achieve therapeutic effect through genetic modifications of human cells using retroviral or lentiviral vectors, resulting in permanent or long-acting changes in the human body. With this genetic modification comes risk of undesirable adverse events. Due to this risk, the Food and Drug Administration (FDA) and the Center for Biologics Evaluation and resea…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Receipt of a genetically modified cell product on a St. Jude investigator-initiated study within the prior 15 years.
Exclusion Criteria:
* Inability or unwillingness of research participant and/or legal guardian/ representative to give written informed consent.
Contacts